A research team from the Korea Advanced Institute of Science and Technology (KAIST) has developed a robot skin that can sense external tactile stimuli and recover from injury when damaged.
The newly developed robot skin can sense pressure and vibration in real time with a small number of measuring elements by mimicking the structure of human skin and the properties and composition of tactile receptors.
By processing measured tactile signals through an artificial intelligence (AI)-based neural network, it can also classify the types of tactile stimuli such as pressing, tapping, and patting.
The robot skin, made of soft materials such as hydrogel and silicone, can absorb shock and easily recover structure and function even when it is torn or cut deeply by a sharp object.
The research team expects the robot skin to be used for restaurant serving robots and human-type robots that interact with humans because it can provide accurate tactile sensation over a large area and have material properties and textures that are similar to human skin.
When used on a prosthetic hand or leg, the robot skin can mimic the appearance and feel of real skin.


FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 



